Published in Proc Natl Acad Sci U S A on April 26, 1994
Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev (1996) 3.46
Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun (1999) 2.26
Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev (2009) 2.20
Bacterial toxins that target Rho proteins. J Clin Invest (1997) 1.69
Crystal structures reveal a thiol protease-like catalytic triad in the C-terminal region of Pasteurella multocida toxin. Proc Natl Acad Sci U S A (2007) 1.56
Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci (2010) 1.50
Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients. Infect Immun (2000) 1.47
Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect Immun (2006) 1.45
Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun (2000) 1.40
Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology (2011) 1.40
Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med (2006) 1.38
A genomic sample sequence of the entomopathogenic bacterium Photorhabdus luminescens W14: potential implications for virulence. Appl Environ Microbiol (2000) 1.36
Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells. Infect Immun (1996) 1.30
Mechanisms of bacterial pathogenicity. Postgrad Med J (2002) 1.29
Escherichia coli cytotoxic necrotizing factor 1: evidence for induction of actin assembly by constitutive activation of the p21 Rho GTPase. Infect Immun (1995) 1.28
Effect of cytolethal distending toxin on F-actin assembly and cell division in Chinese hamster ovary cells. Infect Immun (1997) 1.27
Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun (1995) 1.26
Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infect Immun (1994) 1.25
The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step. Mol Biol Cell (2000) 1.21
Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue. Infect Immun (1998) 1.19
Bacterial toxins: friends or foes? Emerg Infect Dis (1999) 1.18
Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect Immun (2001) 1.18
Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells. Infect Immun (1998) 1.17
Pathogenicity of the diffusely adhering strain Escherichia coli C1845: F1845 adhesin-decay accelerating factor interaction, brush border microvillus injury, and actin disassembly in cultured human intestinal epithelial cells. Infect Immun (1996) 1.14
Rapid and specific detection of F17-related pilin and adhesin genes in diarrheic and septicemic Escherichia coli strains by multiplex PCR. J Clin Microbiol (1996) 1.10
Characterization of the membrane-targeting C1 domain in Pasteurella multocida toxin. J Biol Chem (2010) 1.10
Pasteurella multocida toxin is a mitogen for bone cells in primary culture. Infect Immun (1996) 1.10
Mitotic block and delayed lethality in HeLa epithelial cells exposed to Escherichia coli BM2-1 producing cytotoxic necrotizing factor type 1. Infect Immun (1996) 1.08
Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect Immun (2002) 1.08
Characterization of the roles of hemolysin and other toxins in enteropathy caused by alpha-hemolytic Escherichia coli linked to human diarrhea. Infect Immun (1998) 1.08
Type III secretion-dependent cell cycle block caused in HeLa cells by enteropathogenic Escherichia coli O103. Infect Immun (2001) 1.07
Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida. FEBS J (2011) 1.06
Enteropathogenic Escherichia coli O103 from rabbit elicits actin stress fibers and focal adhesions in HeLa epithelial cells, cytopathic effects that are linked to an analog of the locus of enterocyte effacement. Infect Immun (1997) 1.05
Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus. Infect Immun (1999) 1.03
Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin. Infect Immun (2000) 1.02
Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli. Infect Immun (2008) 1.02
Identification of functional domains of Bordetella dermonecrotizing toxin. Infect Immun (1999) 0.98
The Hha protein as a modulator of expression of virulence factors in Escherichia coli. Infect Immun (1996) 0.97
Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli. Infect Immun (2001) 0.95
Lack of a role of cytotoxic necrotizing factor 1 toxin from Escherichia coli in bacterial pathogenicity and host cytokine response in infected germfree piglets. Infect Immun (2000) 0.94
Two domains of cytotoxic necrotizing factor type 1 bind the cellular receptor, laminin receptor precursor protein. Infect Immun (2007) 0.93
Effects of cytotoxic necrotizing factor 1 and lethal toxin on actin cytoskeleton and VE-cadherin localization in human endothelial cell monolayers. Infect Immun (1999) 0.92
Intestinal epithelial cells and their role in innate mucosal immunity. Cell Tissue Res (2010) 0.92
Membrane interaction of Pasteurella multocida toxin involves sphingomyelin. FEBS J (2011) 0.92
Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp. Infect Immun (1996) 0.91
Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1. Infect Immun (1999) 0.91
Cleavage of Escherichia coli cytotoxic necrotizing factor 1 is required for full biologic activity. Infect Immun (2009) 0.85
Multiplex PCRs for identification of necrotoxigenic Escherichia coli. J Clin Microbiol (2003) 0.81
Association of Pasteurella multocida toxin with vimentin. Infect Immun (2002) 0.81
Cytotoxic necrotizing factor 1 of Escherichia coli stimulates Rho/Rho-kinase-dependent myosin light-chain phosphorylation without inactivating myosin light-chain phosphatase in endothelial cells. Infect Immun (2003) 0.81
Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene. Infect Immun (2001) 0.80
Transport proteins promoting Escherichia coli pathogenesis. Microb Pathog (2014) 0.79
Pasteurella multocida toxin interaction with host cells: entry and cellular effects. Curr Top Microbiol Immunol (2012) 0.77
Determinants of pH-dependent modulation of translocation in dermonecrotic G-protein-deamidating toxins. Toxins (Basel) (2013) 0.76
Presence of pathogenicity island related and plasmid encoded virulence genes in cytolethal distending toxin producing Escherichia coli isolates from diarrheal cases. Int J Appl Basic Med Res (2015) 0.75
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell (1992) 30.02
Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun (1982) 13.55
Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol (1991) 5.72
Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol (1990) 4.83
The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J (1989) 4.21
A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated, or identical, with colicine V. J Gen Microbiol (1974) 3.82
Bacterial toxins: cellular mechanisms of action. Microbiol Rev (1984) 3.42
Construction of vectors with the p15a replicon, kanamycin resistance, inducible lacZ alpha and pUC18 or pUC19 multiple cloning sites. Nucleic Acids Res (1990) 2.77
Partial purification and characterization of an escherichia coli toxic factor that induces morphological cell alterations. Infect Immun (1983) 2.69
Ras-related GTPases and the cytoskeleton. Mol Biol Cell (1992) 2.35
Identification of distinct cytoplasmic targets for ras/R-ras and rho regulatory proteins. J Biol Chem (1989) 2.15
Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol (1987) 2.07
Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur J Biochem (1992) 1.94
Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol Microbiol (1993) 1.77
Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc Natl Acad Sci U S A (1990) 1.71
Cytoskeletal changes induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli. Toxicon (1988) 1.64
Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli. Infect Immun (1993) 1.62
Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem (1992) 1.52
Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli. J Clin Microbiol (1990) 1.49
Jury returns on structure prediction. Nature (1992) 1.48
A cell division-active protein from E. coli. Biochem Biophys Res Commun (1984) 1.45
Characterization and expression of the human rhoH12 gene product. Mol Cell Biol (1989) 1.43
The complete nucleotide sequence of the Pasteurella multocida toxin gene and evidence for a transcriptional repressor, TxaR. Mol Microbiol (1990) 1.37
Cytotoxins in non-enterotoxigenic strains of Escherichia coli isolated from feces of diarrheic calves. Vet Microbiol (1987) 1.36
Pasteurella multocida toxin selectively facilitates phosphatidylinositol 4,5-bisphosphate hydrolysis by bombesin, vasopressin, and endothelin. Requirement for a functional G protein. J Biol Chem (1992) 1.26
Virulence factors associated with cytotoxic necrotizing factor type two in bovine diarrheic and septicemic strains of Escherichia coli. J Clin Microbiol (1991) 1.23
Immunochemical identification and biological characterization of cytotoxic necrotizing factor from Escherichia coli. J Clin Microbiol (1989) 1.20
Serogroups of Escherichia coli strains producing cytotoxic necrotizing factors CNF1 and CNF2. FEMS Microbiol Lett (1992) 1.17
Sequence analysis of the potent mitogenic toxin of Pasteurella multocida. FEBS Lett (1990) 1.16
The primary structure of the yeast hexokinase PII gene (HXK2) which is responsible for glucose repression. Gene (1985) 1.16
Cytotoxic effect of multinucleation in HeLa cell cultures associated with the presence of Vir plasmid in Escherichia coli strains. FEMS Microbiol Lett (1989) 1.13
A single protein of 110 kDa is associated with the multinucleating and necrotizing activity coded by the Vir plasmid of Escherichia coli. FEMS Microbiol Lett (1990) 1.07
Occurrence of the vir plasmid among animal and human strains of invasive Escherichia coli. Am J Vet Res (1980) 0.95
An in vivo assay for the detection of cytotoxic strains of Escherichia coli. Ann Rech Vet (1989) 0.93
Escherichia coli producing CNF1 and CNF2 cytotoxins in animals with different disorders. Vet Res (1993) 0.93
Isolation and characterization of a brefeldin A-resistant mutant of monkey kidney Vero cells. Exp Cell Res (1992) 0.91
Toxic effects for lambs of cytotoxic necrotising factor from Escherichia coli. Res Vet Sci (1990) 0.89
Experimental infection of neonatal pigs with CNF toxin-producing strains of Escherichia coli. Res Vet Sci (1993) 0.88
Genetic and molecular characteristics of Vir plasmids of bovine septicemic Escherichia coli. J Bacteriol (1980) 0.86
[The nicotinic acid and rifampicin tests in Gilbert's syndrome]. Rev Esp Enferm Apar Dig (1985) 0.79
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
The protein-protein interaction map of Helicobacter pylori. Nature (2001) 8.71
Shiga and Shiga-like toxins. Microbiol Rev (1987) 8.58
Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun (1986) 8.09
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (1984) 7.94
Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem (1999) 6.67
Lipoproteins in bacteria. J Bioenerg Biomembr (1990) 5.96
Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J Bacteriol (1988) 5.43
Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol (1983) 5.22
Proteins of the outer membrane of gram-negative bacteria. Annu Rev Microbiol (1980) 5.05
Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun (1985) 5.04
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun (1991) 4.63
Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med (1979) 4.36
Biogenesis of lipoproteins in bacteria. Curr Top Microbiol Immunol (1986) 4.23
The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J (1989) 4.21
The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest (1993) 4.11
Expression of Helicobacter pylori urease genes in Escherichia coli grown under nitrogen-limiting conditions. J Bacteriol (1992) 4.02
Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol (1988) 3.98
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun (1987) 3.96
Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun (1983) 3.85
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76
Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange. J Bacteriol (1992) 3.75
Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. Science (1985) 3.66
Production of Shiga-like toxin by Escherichia coli. J Infect Dis (1986) 3.53
Isolation and characterization of a phosphonomycin-resistant mutant of Escherichia coli K-12. J Bacteriol (1972) 3.38
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
An Escherichia coli mutant with an amino acid alteration within the signal sequence of outer membrane prolipoprotein. Proc Natl Acad Sci U S A (1978) 3.33
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol (1980) 3.31
Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature (1997) 3.31
Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb Pathog (1987) 3.25
A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-alanine amidase domain and an endo-beta-N-acetylglucosaminidase domain: cloning, sequence analysis, and characterization. Proc Natl Acad Sci U S A (1995) 3.12
Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol (1988) 3.11
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun (1988) 3.11
Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet (1984) 3.05
Isolation and characterization of an Escherichia coli mutant with alteration in the outer membrane porteins of the cell envelope. Biochim Biophys Acta (1972) 3.03
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1990) 3.00
Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94
Lipid modification of bacterial prolipoprotein. Transfer of diacylglyceryl moiety from phosphatidylglycerol. J Biol Chem (1994) 2.92
Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol (1996) 2.85
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82
Isolation and characterization of a glucosamine-requiring mutant of Escherichia coli K-12 defective in glucosamine-6-phosphate synthetase. J Bacteriol (1971) 2.80
Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay. J Clin Microbiol (1988) 2.76
Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin. J Cell Biol (1985) 2.71
Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci U S A (1995) 2.70
Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun (1995) 2.69
Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest (2001) 2.67
Nucleotide sequence and expression of the diphtheria tox228 gene in Escherichia coli. Science (1983) 2.65
Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol (1992) 2.65
Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med (1975) 2.57
The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol (1991) 2.54
An autolysin ring associated with cell separation of Staphylococcus aureus. J Bacteriol (1996) 2.52
Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins. Infect Immun (1982) 2.50
Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein. J Bacteriol (1978) 2.48
Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. Proc Natl Acad Sci U S A (1982) 2.40
Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun (1993) 2.38
Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun (1998) 2.37
Purification and properties of beta-N-acetylglucosaminidase from Escherichia coli. J Bacteriol (1976) 2.36
Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun (1990) 2.32
Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature (1982) 2.29
Binding of triton X-100 to diphtheria toxin, crossreacting material 45, and their fragments. Proc Natl Acad Sci U S A (1976) 2.27
Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry (1969) 2.24
Two forms of a structural lipoprotein in the envelope of Escherichia coli. Further characterization of the free form. J Biol Chem (1973) 2.21
Determination of transcriptional units and gene products from the ftsA region of Escherichia coli. J Bacteriol (1980) 2.20
Comparative ultrastructural and functional studies of Helicobacter pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA and FlaB, are necessary for full motility in Helicobacter species. J Bacteriol (1995) 2.15
Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun (1995) 2.15
Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6J mice. Infect Immun (1984) 2.15
Polymerase chain reaction assay for diagnosis of potentially toxinogenic Corynebacterium diphtheriae strains: correlation with ADP-ribosylation activity assay. J Clin Microbiol (1993) 2.14
Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest (1995) 2.14
The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition. Infect Immun (1990) 2.14
Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem (1989) 2.12
Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation (1979) 2.11
Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique. Res Microbiol (1996) 2.11
Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem (1994) 2.09
The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J (2000) 2.08
Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill (2007) 2.07
The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun (1998) 2.05
Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect Immun (1996) 2.04
Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther (1977) 2.03
Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activity. Int J Epidemiol (1995) 2.00
Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli. Infect Immun (1993) 1.99
The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A (1995) 1.99
Perioperative myocardial infarction in noncardiac surgery: the diagnostic and prognostic role of cardiac troponins. J Intern Med (2002) 1.98
High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int Immunol (1996) 1.97
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant (2000) 1.95
Flagella help Salmonella typhimurium survive within murine macrophages. Infect Immun (1984) 1.95
Genetic control of resistance to infection in mice. Crit Rev Immunol (1982) 1.93
Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin. Biochem Biophys Res Commun (1988) 1.92
Shiga-like toxin production from Escherichia coli associated with calf diarrhoea. Vet Rec (1985) 1.91
Effect of silica on the innate resistance of inbred mice to Salmonella typhimurium infection. Infect Immun (1979) 1.91
Essential role of Helicobacter pylori gamma-glutamyltranspeptidase for the colonization of the gastric mucosa of mice. Mol Microbiol (1999) 1.91
Control of early Salmonella typhimurium growth in innately Salmonella-resistant mice does not require functional T lymphocytes. J Immunol (1982) 1.90
Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function. J Immunol (1979) 1.90
Role of guanine nucleotide-binding proteins--ras-family or trimeric proteins or both--in Ca2+ sensitization of smooth muscle. Proc Natl Acad Sci U S A (1996) 1.87
Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet (1983) 1.87